AAPL356.91+2.03 (+0.57%) ▲|ABBV295.93+1.48 (+0.50%) ▲|ABT108.64+1.39 (+1.30%) ▲|ACN252.01+2.06 (+0.82%) ▲|ADBE243.50+4.96 (+2.08%) ▲|AMAT368.98-11.97 (-3.14%) ▼|AMD533.26-52.04 (-8.89%) ▼|AMGN466.58-0.48 (-0.10%) ▼|AMT191.24+1.45 (+0.76%) ▲|AMZN265.57-1.88 (-0.70%) ▼|AVGO345.73-18.64 (-5.11%) ▼|AXP319.42+1.36 (+0.43%) ▲|BA171.17-0.38 (-0.22%) ▼|BAC50.77+0.26 (+0.50%) ▲|BKNG159.87-1.33 (-0.82%) ▼|BLK1,217.13+0.52 (+0.04%) ▲|BMY63.64+1.32 (+2.12%) ▲|BNY152.49-0.30 (-0.20%) ▼|BRK-B591.34+1.51 (+0.26%) ▲|C123.81-0.25 (-0.20%) ▼|CAT597.13-8.15 (-1.35%) ▼|CL99.40+1.50 (+1.53%) ▲|CMCSA25.08+0.28 (+1.11%) ▲|COF194.67+1.07 (+0.55%) ▲|COP142.39+2.33 (+1.66%) ▲|COST1,103.49+11.28 (+1.03%) ▲|CRM218.42+0.85 (+0.39%) ▲|CSCO95.82-6.20 (-6.07%) ▼|CVS88.89-0.90 (-1.00%) ▼|CVX218.74+2.39 (+1.10%) ▲|DE671.80-7.00 (-1.03%) ▼|DHR233.44+1.28 (+0.55%) ▲|DIS119.07+0.84 (+0.71%) ▲|DUK129.57+2.07 (+1.62%) ▲|EMR165.74-0.59 (-0.35%) ▼|FDX322.65+3.35 (+1.05%) ▲|GD362.35-0.72 (-0.20%) ▼|GE331.07+0.21 (+0.06%) ▲|GEV795.75-22.74 (-2.78%) ▼|GILD168.53+0.58 (+0.35%) ▲|GM86.14-0.11 (-0.13%) ▼|GOOG292.33-3.02 (-1.02%) ▼|GOOGL295.39-3.31 (-1.11%) ▼|GS913.45-0.15 (-0.02%) ▼|HD347.83-0.43 (-0.12%) ▼|HON222.38-0.37 (-0.17%) ▼|IBM247.66+2.99 (+1.22%) ▲|INTC59.44-1.77 (-2.88%) ▼|INTU341.70+1.53 (+0.45%) ▲|ISRG446.10+6.21 (+1.41%) ▲|JNJ286.74+3.22 (+1.14%) ▲|JPM344.47+1.65 (+0.48%) ▲|KO99.20+1.76 (+1.81%) ▲|LIN524.83+2.34 (+0.45%) ▲|LLY1,445.84+20.29 (+1.42%) ▲|LMT593.98-10.11 (-1.67%) ▼|LOW227.32-0.14 (-0.06%) ▼|LRCX225.31-8.47 (-3.62%) ▼|MA660.52+7.92 (+1.21%) ▲|MCD272.64-0.99 (-0.36%) ▼|MDLZ67.36+0.80 (+1.19%) ▲|MDT102.93+1.94 (+1.92%) ▲|META640.86+17.25 (+2.77%) ▲|MMM184.53-0.93 (-0.50%) ▼|MO78.62+0.70 (+0.90%) ▲|MRK147.76+0.81 (+0.55%) ▲|MS189.97+0.80 (+0.42%) ▲|MSFT524.69+1.69 (+0.32%) ▲|MU771.61-26.83 (-3.36%) ▼|NEE84.94-0.35 (-0.41%) ▼|NFLX62.30-0.40 (-0.63%) ▼|NKE38.00+0.24 (+0.62%) ▲|NOW102.60+1.94 (+1.93%) ▲|NVDA162.42-3.78 (-2.27%) ▼|ORCL125.33-1.78 (-1.40%) ▼|PEP144.88+2.62 (+1.84%) ▲|PFE28.86+0.03 (+0.09%) ▲|PG169.86+1.83 (+1.09%) ▲|PLTR168.45-3.13 (-1.82%) ▼|PM198.47+1.81 (+0.92%) ▲|QCOM173.00-4.14 (-2.34%) ▼|RTX198.13-0.23 (-0.12%) ▼|SBUX106.87+0.24 (+0.23%) ▲|SCHW92.66+1.26 (+1.37%) ▲|SO93.58+1.11 (+1.20%) ▲|SPG233.23-0.39 (-0.16%) ▼|T22.23+0.05 (+0.24%) ▲|TMO699.78+0.34 (+0.05%) ▲|TMUS170.46-0.57 (-0.33%) ▼|TSLA390.77-6.68 (-1.68%) ▼|TXN303.68-8.80 (-2.82%) ▼|UBER69.38+0.26 (+0.38%) ▲|UNH408.25+3.12 (+0.77%) ▲|UNP302.01-2.19 (-0.72%) ▼|UPS112.45+2.07 (+1.88%) ▲|USB60.89+0.42 (+0.69%) ▲|V425.33+5.02 (+1.19%) ▲|VZ46.38-0.17 (-0.37%) ▼|WFC85.70-0.06 (-0.07%) ▼|WMT127.74+1.55 (+1.23%) ▲|XOM170.08+0.30 (+0.18%) ▲|AAPL356.91+2.03 (+0.57%) ▲|ABBV295.93+1.48 (+0.50%) ▲|ABT108.64+1.39 (+1.30%) ▲|ACN252.01+2.06 (+0.82%) ▲|ADBE243.50+4.96 (+2.08%) ▲|AMAT368.98-11.97 (-3.14%) ▼|AMD533.26-52.04 (-8.89%) ▼|AMGN466.58-0.48 (-0.10%) ▼|AMT191.24+1.45 (+0.76%) ▲|AMZN265.57-1.88 (-0.70%) ▼|AVGO345.73-18.64 (-5.11%) ▼|AXP319.42+1.36 (+0.43%) ▲|BA171.17-0.38 (-0.22%) ▼|BAC50.77+0.26 (+0.50%) ▲|BKNG159.87-1.33 (-0.82%) ▼|BLK1,217.13+0.52 (+0.04%) ▲|BMY63.64+1.32 (+2.12%) ▲|BNY152.49-0.30 (-0.20%) ▼|BRK-B591.34+1.51 (+0.26%) ▲|C123.81-0.25 (-0.20%) ▼|CAT597.13-8.15 (-1.35%) ▼|CL99.40+1.50 (+1.53%) ▲|CMCSA25.08+0.28 (+1.11%) ▲|COF194.67+1.07 (+0.55%) ▲|COP142.39+2.33 (+1.66%) ▲|COST1,103.49+11.28 (+1.03%) ▲|CRM218.42+0.85 (+0.39%) ▲|CSCO95.82-6.20 (-6.07%) ▼|CVS88.89-0.90 (-1.00%) ▼|CVX218.74+2.39 (+1.10%) ▲|DE671.80-7.00 (-1.03%) ▼|DHR233.44+1.28 (+0.55%) ▲|DIS119.07+0.84 (+0.71%) ▲|DUK129.57+2.07 (+1.62%) ▲|EMR165.74-0.59 (-0.35%) ▼|FDX322.65+3.35 (+1.05%) ▲|GD362.35-0.72 (-0.20%) ▼|GE331.07+0.21 (+0.06%) ▲|GEV795.75-22.74 (-2.78%) ▼|GILD168.53+0.58 (+0.35%) ▲|GM86.14-0.11 (-0.13%) ▼|GOOG292.33-3.02 (-1.02%) ▼|GOOGL295.39-3.31 (-1.11%) ▼|GS913.45-0.15 (-0.02%) ▼|HD347.83-0.43 (-0.12%) ▼|HON222.38-0.37 (-0.17%) ▼|IBM247.66+2.99 (+1.22%) ▲|INTC59.44-1.77 (-2.88%) ▼|INTU341.70+1.53 (+0.45%) ▲|ISRG446.10+6.21 (+1.41%) ▲|JNJ286.74+3.22 (+1.14%) ▲|JPM344.47+1.65 (+0.48%) ▲|KO99.20+1.76 (+1.81%) ▲|LIN524.83+2.34 (+0.45%) ▲|LLY1,445.84+20.29 (+1.42%) ▲|LMT593.98-10.11 (-1.67%) ▼|LOW227.32-0.14 (-0.06%) ▼|LRCX225.31-8.47 (-3.62%) ▼|MA660.52+7.92 (+1.21%) ▲|MCD272.64-0.99 (-0.36%) ▼|MDLZ67.36+0.80 (+1.19%) ▲|MDT102.93+1.94 (+1.92%) ▲|META640.86+17.25 (+2.77%) ▲|MMM184.53-0.93 (-0.50%) ▼|MO78.62+0.70 (+0.90%) ▲|MRK147.76+0.81 (+0.55%) ▲|MS189.97+0.80 (+0.42%) ▲|MSFT524.69+1.69 (+0.32%) ▲|MU771.61-26.83 (-3.36%) ▼|NEE84.94-0.35 (-0.41%) ▼|NFLX62.30-0.40 (-0.63%) ▼|NKE38.00+0.24 (+0.62%) ▲|NOW102.60+1.94 (+1.93%) ▲|NVDA162.42-3.78 (-2.27%) ▼|ORCL125.33-1.78 (-1.40%) ▼|PEP144.88+2.62 (+1.84%) ▲|PFE28.86+0.03 (+0.09%) ▲|PG169.86+1.83 (+1.09%) ▲|PLTR168.45-3.13 (-1.82%) ▼|PM198.47+1.81 (+0.92%) ▲|QCOM173.00-4.14 (-2.34%) ▼|RTX198.13-0.23 (-0.12%) ▼|SBUX106.87+0.24 (+0.23%) ▲|SCHW92.66+1.26 (+1.37%) ▲|SO93.58+1.11 (+1.20%) ▲|SPG233.23-0.39 (-0.16%) ▼|T22.23+0.05 (+0.24%) ▲|TMO699.78+0.34 (+0.05%) ▲|TMUS170.46-0.57 (-0.33%) ▼|TSLA390.77-6.68 (-1.68%) ▼|TXN303.68-8.80 (-2.82%) ▼|UBER69.38+0.26 (+0.38%) ▲|UNH408.25+3.12 (+0.77%) ▲|UNP302.01-2.19 (-0.72%) ▼|UPS112.45+2.07 (+1.88%) ▲|USB60.89+0.42 (+0.69%) ▲|V425.33+5.02 (+1.19%) ▲|VZ46.38-0.17 (-0.37%) ▼|WFC85.70-0.06 (-0.07%) ▼|WMT127.74+1.55 (+1.23%) ▲|XOM170.08+0.30 (+0.18%) ▲|
5.1 C
New York
Friday, November 13, 2026

Tag: development

Advancing Global Tourism Industry Trade: Tourism Plus Shanghai 2026 Calls for Worldwide Exhibitors

SHANGHAI, Aug. 3, 2025 /PRNewswire/ -- From March 29th to April 3rd, 2026, Tourism Plus Shanghai (TPS 2026) will convene over 6,000 global exhibitors in...

Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE

SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently...

Zepp Health Corporation Reports Second Quarter 2025 Unaudited Financial Results

MILPITAS, Calif., Aug. 3, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India,...

INVESTOR PRESENTATION

PERTH, Australia, Aug. 4, 2025 /CNW/ - Paladin Energy Ltd (ASX: PDN) (TSX: PDN) (OTCQX: PALAF) ("Paladin" or the "Company") advises that it has...

AAPL LEGAL ALERT: Lose Money on Your Apple Inc. Investment? Contact BFA Law by August 19 Class Action Deadline (NASDAQ:AAPL)

Apple Inc. investors that lost money are notified to contact BFA Law before the August 19, 2025 securities fraud class action deadline.

First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma’s Investigational Antidepressant Targeting NET/DAT/GABAAR

SHANGHAI, Aug. 3, 2025 /PRNewswire/ -- Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in...

Pilly Labs Formulates 2025’s Top Mushroom Extract Gummies Supplement for ADHD Focus, Anxiety Support, and Natural Weight Wellness

As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.
As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.

Chaga Mushroom Supplement Surge: Why Pilly Labs’ 2025 Formula Is Reshaping Immune Health Conversations

Interest in Chaga mushroom supplements is surging across 2025 wellness trends, as consumers seek cleaner, science-aligned alternatives for immune support, inflammation balance, and energy recovery. With dual-extracted fruiting body sourcing and lab-tested transparency, Pilly Labs’ latest formula is gaining attention as a serious contender in the adaptogenic mushroom space—without the hype or filler.
Interest in Chaga mushroom supplements is surging across 2025 wellness trends, as consumers seek cleaner, science-aligned alternatives for immune support, inflammation balance, and energy recovery. With dual-extracted fruiting body sourcing and lab-tested transparency, Pilly Labs’ latest formula is gaining attention as a serious contender in the adaptogenic mushroom space—without the hype or filler.

Matsato Knife Official Launch in Australia, USA – Redefining Precision and Power in the Kitchen

Matsato Kitchen Knife official launch of the Matsato Knife a high-performance culinary blade crafted for chefs and home cooks across Australia, the United States, Canada, and the UK. Engineered for razor-sharp precision, ergonomic comfort, and long-lasting durability. transform your cooking experience
Matsato Kitchen Knife official launch of the Matsato Knife a high-performance culinary blade crafted for chefs and home cooks across Australia, the United States, Canada, and the UK. Engineered for razor-sharp precision, ergonomic comfort, and long-lasting durability. transform your cooking experience

Shiba Inu Coin Gains Utility and Community Strength as HashJ Launches SHIB Focused Contracts

London, United Kingdom, Aug. 02, 2025 (GLOBE NEWSWIRE) -- MGPD Finance Limited, doing business as HashJ, today announced the official launch of its short-term contracts dedicated to Shiba Inu Coin (SHIB), one of the most community-driven digital assets in the market. The new offering allows everyday users to engage with SHIB-linked reward plans designed for shorter durations and predictable outcomes—particularly as SHIB’s utility and adoption continue to expand globally.

Risetcar’s driverless taxis are performing well in the US, with Jakarta operations set to launch soon

BOSTON, MA, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Risetcar, an autonomous transportation technology company, has launched its self-driving taxi service in several US cities and achieved encouraging results. The company has received positive customer feedback and generated stable profits.

Launch of Global Impact Champions Awards for Financial Health

SINGAPORE, Aug. 2, 2025 /PRNewswire/ -- The Global Finance & Technology Network (GFTN) has launched the inaugural Global Impact Champions Awards, with the 2025...

Bitcoin Swift Launches Stage 3 Presale With AI-Driven Proof-of-Yield Rewards System

LUXEMBOURG , Aug. 02, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift, a blockchain protocol combining Proof-of-Work (PoW), Proof-of-Stake (PoS), and an AI-powered Proof-of-Yield (PoY) mechanism, has officially entered Stage 3 of its presale. The platform is offering tokens at $3 during this limited 64-day window, with a scheduled increase to $4 in the next stage and a confirmed launch price of $15.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment